| Completed | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects Prostate Cancer | Phase 1 | 2023-08-10 |
| Terminated | Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Component Dyskinesias, Parkinson Disease | Phase 2 | 2021-04-28 |
| Completed | The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and COVID-19 | Phase 2 | 2021-03-19 |
| Completed | The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 COVID-19 | Phase 2 | 2020-05-26 |
| Completed | A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizo Schizophrenia | Phase 3 | 2018-04-09 |
| Completed | A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment Gastric Cancer | Phase 1 | 2016-03-01 |
| Completed | Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia Parkinson's Disease, Levodopa Induced Dyskinesia (LID) | Phase 2 | 2015-05-01 |
| Completed | A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil Healthy | Phase 1 | 2012-04-01 |
| Completed | Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury Spinal Cord Injury | Phase 1 | 2012-04-01 |
| Completed | Comparative Efficacy and Safety of Fenoverine Irritable Bowel Syndrome | Phase 4 | 2011-12-01 |
| Completed | Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiv Hepatitis C | Phase 3 | 2010-11-01 |
| Completed | Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects Diabetic Neuropathies | Phase 3 | 2010-08-01 |
| Completed | A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in P Hepatitis B Associated Hepatocellular Carcinoma | Phase 4 | 2010-06-01 |
| Completed | An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination Chronic Hepatitis B | Phase 4 | 2010-03-01 |
| Terminated | A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevud Chronic Hepatitis B | Phase 4 | 2009-11-01 |
| Terminated | A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B Chronic Hepatitis B | Phase 4 | 2009-09-01 |
| Completed | A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult M Healthy Adult Male | Phase 1 | 2009-08-01 |
| Terminated | A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in t Chronic Hepatitis B | Phase 4 | 2009-08-01 |
| Completed | An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related S Chronic Hepatitis B | — | 2009-04-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudin HBeAg(+) Chronic Hepatitis B | Phase 4 | 2008-12-01 |
| Completed | A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and HBeAg(-) Chronic Hepatitis B With Compensated Liver Function | Phase 4 | 2008-02-01 |
| Completed | A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B Patients With LC-B | Phase 3 | 2007-12-01 |
| Completed | Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients Chronic Hepatitis B | Phase 4 | 2007-11-01 |
| Completed | Long-term Study With Clevudine Chronic Hepatitis B | Phase 4 | 2007-06-01 |
| Completed | Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HB Hepatitis B | Phase 4 | 2007-05-01 |
| Completed | Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infec Hepatitis B | Phase 3 | 2006-08-01 |
| Completed | Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Hepatitis B | — | 2005-06-01 |
| Terminated | Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials Hepatitis B | Phase 3 | 2004-06-01 |
| Terminated | Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 Hepatitis B | Phase 2 | 2003-07-01 |
| Terminated | Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV Hepatitis B | Phase 3 | 2003-07-01 |
| Terminated | Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV Hepatitis B | Phase 3 | 2003-06-01 |
| Terminated | Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group Hepatitis B | Phase 2 | 2003-06-01 |
| Terminated | Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus Hepatitis B | Phase 2 | 2002-07-01 |